Horst et al.[29] found a significant correlation between endoluminal surface CD133 expression and low survival in CRC patients, while Xi et al.[54] reported that CD133 expression in membrane and cytoplasm of cells on the luminal surface of cancerous glands was of prognostic value in CRC patients. The gene discussed is PROM1; the disease is colorectal carcinoma.